Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.08 AUD Market Closed
Market Cap: 50m AUD

EV/EBITDA
Enterprise Value to EBITDA

-22.8
Current
-18.3
Median
11.4
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-22.8
=
Enterprise Value
56.3m AUD
/
EBITDA
-2.5m AUD
EBITDA Growth EV/EBITDA to Growth
AU
Medadvisor Ltd
ASX:MDR
Average EV/EBITDA: 84.9
Negative Multiple: -22.8
60%
N/A
US
Veeva Systems Inc
NYSE:VEEV
48.7
38%
1.3
US
C
Cerner Corp
LSE:0R00
21.9
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
201.4
38%
5.3
US
Doximity Inc
NYSE:DOCS
41.2
21%
2
JP
M3 Inc
TSE:2413
19
13%
1.5
US
W
Waystar Holding Corp
NASDAQ:WAY
22.8
18%
1.3
SE
Sectra AB
STO:SECT B
Negative Multiple: -132.1 N/A N/A
US
Inspire Medical Systems Inc
NYSE:INSP
59.6
90%
0.7
IN
I
Inventurus Knowledge Solutions Ltd
NSE:IKS
Not Available N/A N/A
US
V
Vocera Communications Inc
F:V00
265
N/A N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-11
2-Years Forward
EV/EBITDA
6.9
3-Years Forward
EV/EBITDA
5.1